Exact Sciences (EXAS) PT Raised to $105 at UBS as Abbott Deal Expected to Close in 2Q26
Tweet Send to a Friend
UBS analyst Dan Leonard raised the price target on Exact Sciences (NASDAQ: EXAS) to $105.00 (from $80.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
